The use of genomic variants to drive drug repurposing for chronic hepatitis B

BACKGROUND: One of the main challenges in personalized medicine is to establish and apply a large number of variants from genomic databases into clinical diagnostics and further facilitate genome-driven drug repurposing. By utilizing biological chronic hepatitis B infection (CHB) risk genes, our stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Irham, Lalu Muhammad, Adikusuma, Wirawan, Perwitasari, Dyah Aryani, Dania, Haafizah, Maliza, Rita, Faridah, Imaniar Noor, Santri, Ichtiarini Nurullita, Phiri, Yohane Vincent Abero, Cheung, Rocky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271961/
https://www.ncbi.nlm.nih.gov/pubmed/35832745
http://dx.doi.org/10.1016/j.bbrep.2022.101307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271961/
https://www.ncbi.nlm.nih.gov/pubmed/35832745
http://dx.doi.org/10.1016/j.bbrep.2022.101307

Ejemplares similares